Platform
SHIFTBIO has achieved significant savings in unit production costs through NNP process development that ensures high purity and yield
Stably Transduced Modified Cell Bank (stMCB)
Large-scale3D bioreactor
High Purity & High Recovery
Drug Product +QC Release Testing
SHIFTBIO developed a scalable engineered NNP manufacturing platform
delivering high-purity products with exceptional batch consistency
while dramatically reducing production cost
